Combined GIP- and GLP1R activators have the potential to become a treatment option for patients with type 2 diabetes
DREADD ligand injection
R., Oberst A., Dillon C
Water, Glycerin, 1,2-Hexanediol, Glutathione, Glycyrrhiza Glabra (Licorice) Root Extract, Magnesium Ascorbyl Phosphate, Polyglutamic Acid, Ceramide NP, Astragalus Membranaceus Root Extract, Schisandra Chinensis Fruit Water, Butylene Glycol, Hydrogenated Lecithin, Allantoin, Tocopherol, Sodium Citrate, Sodium Phytate, Citric Acid, Polyglyceryl-10 Laurate, Ethylhexylglycerin
First, secondary death should occur in a spatially and temporally ordered manner that is consistent with directional spread rather than random coincidence